• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠肿瘤微环境中的间充质干细胞:最新进展及其意义。

Mesenchymal stem cells in the colorectal tumor microenvironment: recent progress and implications.

机构信息

Discipline of Surgery, School of Medicine, National University of Ireland, Galway, Ireland.

出版信息

Int J Cancer. 2012 Jul 1;131(1):1-7. doi: 10.1002/ijc.27458. Epub 2012 Feb 28.

DOI:10.1002/ijc.27458
PMID:22290082
Abstract

Mesenchymal stem cells (MSCs) are nonhematopoietic multipotent adult stem cells. They have been shown to have a natural tropism for many tumors types, including colorectal, and are capable of escaping host immune surveillance. MSCs are known to engraft at tumors and integrate into their architecture, potentially as carcinoma-associated fibroblasts. In contrast with other malignancies, our understanding of the interactions between colorectal cancer cells and MSCs remains limited. Considering the established importance of inflammation in the colorectal cancer primary tumor microenvironment and the role of stromal cells in this process, there is a potential wealth of information to be gleaned from further investigation of interactions between these cell populations. Epithelial-mesenchymal transition is central to colorectal cancer progression and MSCs have also been implicated in this process. This review explores the current knowledge (both in vitro and in vivo) of interactions between colorectal cancer cells and MSCs. It highlights potential effects of cell source, number and ratio on outcome of in vivo studies and explores strategies to more accurately explore their role in the primary tumor microenvironment. As our understanding of the underlying molecular processes in colorectal cancer develops, elucidation of these interactions will be central to development of novel therapeutic strategies for this prevalent disease.

摘要

间充质干细胞(MSCs)是一种非造血性多能成体干细胞。已证实它们对多种肿瘤类型具有天然的趋向性,包括结直肠肿瘤,并能够逃避宿主的免疫监视。MSCs 已知会在肿瘤部位定植并整合到肿瘤的结构中,可能成为癌相关成纤维细胞。与其他恶性肿瘤相比,我们对结直肠癌细胞与 MSCs 之间相互作用的理解仍然有限。考虑到炎症在结直肠肿瘤原发性肿瘤微环境中的重要作用以及基质细胞在这一过程中的作用,进一步研究这些细胞群体之间的相互作用可能会获得大量有价值的信息。上皮-间充质转化是结直肠肿瘤进展的核心,MSCs 也与这一过程有关。这篇综述探讨了结直肠癌细胞与 MSCs 之间相互作用的现有知识(包括在体和离体研究)。它强调了细胞来源、数量和比例对体内研究结果的潜在影响,并探讨了更准确地探索它们在原发性肿瘤微环境中作用的策略。随着我们对结直肠癌症中潜在分子过程的理解不断发展,阐明这些相互作用将是开发这种常见疾病新型治疗策略的关键。

相似文献

1
Mesenchymal stem cells in the colorectal tumor microenvironment: recent progress and implications.结直肠肿瘤微环境中的间充质干细胞:最新进展及其意义。
Int J Cancer. 2012 Jul 1;131(1):1-7. doi: 10.1002/ijc.27458. Epub 2012 Feb 28.
2
Mesenchymal stem cells promote growth and angiogenesis of tumors in mice.间充质干细胞促进小鼠肿瘤的生长和血管生成。
Oncogene. 2013 Sep 12;32(37):4343-54. doi: 10.1038/onc.2012.458. Epub 2012 Oct 22.
3
Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?间充质基质细胞(MSCs)与结直肠癌:抗肿瘤免疫反应中的一对麻烦搭档?
Oncotarget. 2016 Sep 13;7(37):60752-60774. doi: 10.18632/oncotarget.11354.
4
Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells.间充质干细胞在实体瘤细胞的抑制或进展中犹如一把双刃剑。
Tumour Biol. 2016 Sep;37(9):11679-11689. doi: 10.1007/s13277-016-5187-7. Epub 2016 Jul 20.
5
Mesenchymal stem cells in lung cancer tumor microenvironment: their biological properties, influence on tumor growth and therapeutic implications.肺癌肿瘤微环境中的间充质干细胞:它们的生物学特性、对肿瘤生长的影响及治疗意义。
Cancer Lett. 2014 Oct 28;353(2):145-52. doi: 10.1016/j.canlet.2014.07.047. Epub 2014 Aug 12.
6
Mesenchymal stem cells and cancer: tumor-specific delivery vehicles or therapeutic targets?间充质干细胞与癌症:肿瘤特异性递送载体还是治疗靶点?
Hum Gene Ther. 2010 Nov;21(11):1506-12. doi: 10.1089/hum.2010.135. Epub 2010 Oct 6.
7
Contextual niche signals towards colorectal tumor progression by mesenchymal stem cell in the mouse xenograft model.在小鼠异种移植模型中,间充质干细胞向结直肠肿瘤进展发出的背景生态位信号。
J Gastroenterol. 2015 Sep;50(9):962-74. doi: 10.1007/s00535-015-1049-0. Epub 2015 Feb 14.
8
Mesenchymal stem cells promote formation of colorectal tumors in mice.间质干细胞促进小鼠结直肠肿瘤的形成。
Gastroenterology. 2011 Sep;141(3):1046-56. doi: 10.1053/j.gastro.2011.05.045. Epub 2011 May 31.
9
Multipotent mesenchymal stromal cells in liver cancer: implications for tumor biology and therapy.肝癌中的多能间充质基质细胞:对肿瘤生物学和治疗的意义。
Biochim Biophys Acta. 2014 Dec;1846(2):439-45. doi: 10.1016/j.bbcan.2014.08.008. Epub 2014 Sep 6.
10
Mesenchymal stem cells: key players in cancer progression.间充质干细胞:癌症进展中的关键因素。
Mol Cancer. 2017 Feb 1;16(1):31. doi: 10.1186/s12943-017-0597-8.

引用本文的文献

1
Oxidative High Mobility Group Box-1 Accelerates Mitochondrial Transfer from Mesenchymal Stem Cells to Colorectal Cancer Cells Providing Cancer Cell Stemness.氧化型高迁移率族蛋白盒1促进间充质干细胞向结直肠癌细胞的线粒体转移,赋予癌细胞干性。
Int J Mol Sci. 2025 Jan 30;26(3):1192. doi: 10.3390/ijms26031192.
2
Priming of Colorectal Tumor-Associated Fibroblasts with Zoledronic Acid Conjugated to the Anti-Epidermal Growth Factor Receptor Antibody Cetuximab Elicits Anti-Tumor Vδ2 T Lymphocytes.用与抗表皮生长因子受体抗体西妥昔单抗偶联的唑来膦酸预处理结直肠癌相关成纤维细胞可引发抗肿瘤Vδ2 T淋巴细胞。
Cancers (Basel). 2023 Jan 18;15(3):610. doi: 10.3390/cancers15030610.
3
Exosomal miR-30a and miR-222 derived from colon cancer mesenchymal stem cells promote the tumorigenicity of colon cancer through targeting MIA3.
源自结肠癌间充质干细胞的外泌体miR-30a和miR-222通过靶向MIA3促进结肠癌的致瘤性。
J Gastrointest Oncol. 2021 Feb;12(1):52-68. doi: 10.21037/jgo-20-513.
4
The Achievements and Challenges of Mesenchymal Stem Cell-Based Therapy in Inflammatory Bowel Disease and Its Associated Colorectal Cancer.基于间充质干细胞的疗法在炎症性肠病及其相关结直肠癌中的成就与挑战
Stem Cells Int. 2020 Mar 18;2020:7819824. doi: 10.1155/2020/7819824. eCollection 2020.
5
Mesenchymal stem cells derived from iPSCs expressing interleukin-24 inhibit the growth of melanoma in the tumor-bearing mouse model.源自表达白细胞介素-24的诱导多能干细胞的间充质干细胞在荷瘤小鼠模型中抑制黑色素瘤的生长。
Cancer Cell Int. 2020 Jan 30;20:33. doi: 10.1186/s12935-020-1112-7. eCollection 2020.
6
Stem Cell Therapy for Hepatocellular Carcinoma: Future Perspectives.干细胞治疗肝细胞癌:未来展望。
Adv Exp Med Biol. 2020;1237:97-119. doi: 10.1007/5584_2019_441.
7
Targeting the Epidermal Growth Factor Receptor Can Counteract the Inhibition of Natural Killer Cell Function Exerted by Colorectal Tumor-Associated Fibroblasts.靶向表皮生长因子受体可拮抗结直肠肿瘤相关成纤维细胞对自然杀伤细胞功能的抑制作用。
Front Immunol. 2018 May 29;9:1150. doi: 10.3389/fimmu.2018.01150. eCollection 2018.
8
The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells.hERG1 离子通道在细胞上皮-间质转化中的作用及利鲁唑降低结直肠癌细胞顺铂耐药性的能力。
Cell Oncol (Dordr). 2017 Aug;40(4):367-378. doi: 10.1007/s13402-017-0328-6. Epub 2017 Jun 7.
9
Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease.间充质干细胞及其在炎症性肠病中的治疗应用。
Oncotarget. 2017 Jun 6;8(23):38008-38021. doi: 10.18632/oncotarget.16682.
10
Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?间充质基质细胞(MSCs)与结直肠癌:抗肿瘤免疫反应中的一对麻烦搭档?
Oncotarget. 2016 Sep 13;7(37):60752-60774. doi: 10.18632/oncotarget.11354.